WO2017164659A3 - Method for examining ability of natural material to increase immunocompetence and method for providing customized diet using same - Google Patents

Method for examining ability of natural material to increase immunocompetence and method for providing customized diet using same Download PDF

Info

Publication number
WO2017164659A3
WO2017164659A3 PCT/KR2017/003107 KR2017003107W WO2017164659A3 WO 2017164659 A3 WO2017164659 A3 WO 2017164659A3 KR 2017003107 W KR2017003107 W KR 2017003107W WO 2017164659 A3 WO2017164659 A3 WO 2017164659A3
Authority
WO
WIPO (PCT)
Prior art keywords
individual subjects
natural material
immunocompetence
examining
providing customized
Prior art date
Application number
PCT/KR2017/003107
Other languages
French (fr)
Korean (ko)
Other versions
WO2017164659A2 (en
Inventor
백강민
Original Assignee
온틀협동조합
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온틀협동조합 filed Critical 온틀협동조합
Publication of WO2017164659A2 publication Critical patent/WO2017164659A2/en
Publication of WO2017164659A3 publication Critical patent/WO2017164659A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866Interferon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to a method for examining individual subjects for immunocompetence wherein blood samples from individual subjects are added with antigen cells and assayed for the death of the antigen cells and the levels of cytokines including IFN-γ. The present invention relates to a method for examining a degree to which a natural material increases the immunocompetence of individual subjects, wherein blood samples from the individual subjects are added with antigen cells and the natural material and assayed for the death of the antigen cells and the level of cytokines including IFN-γ. The present invention relates to a method for providing customized diets for increasing the immunocompetence of individual subjects, comprising determining and selecting natural materials for immunopotentiating the individual subjects.
PCT/KR2017/003107 2016-03-23 2017-03-23 Method for examining ability of natural material to increase immunocompetence and method for providing customized diet using same WO2017164659A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160034495A KR20170110297A (en) 2016-03-23 2016-03-23 A method for examining the reinforcement of immunization of natural material, and a method for providing personalized diet thereby
KR10-2016-0034495 2016-03-23

Publications (2)

Publication Number Publication Date
WO2017164659A2 WO2017164659A2 (en) 2017-09-28
WO2017164659A3 true WO2017164659A3 (en) 2018-09-07

Family

ID=59900515

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/003107 WO2017164659A2 (en) 2016-03-23 2017-03-23 Method for examining ability of natural material to increase immunocompetence and method for providing customized diet using same

Country Status (2)

Country Link
KR (1) KR20170110297A (en)
WO (1) WO2017164659A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101981146B1 (en) * 2018-03-26 2019-05-22 충남대학교산학협력단 Method for Evaluating Immune-Boosting Effect and Screening Immunity Materials Using Dendritic Cells
KR101981147B1 (en) * 2018-09-27 2019-05-22 충남대학교산학협력단 Method for Evaluating Immunostimulation Effect of Immuno Materials Using Dendritic Cell and Screening Immuno Materials
WO2023081291A1 (en) * 2021-11-03 2023-05-11 Reichberg Samuel Test to predict and evaluate innate immune responses to infections and methods of treatment thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040047899A (en) * 2002-10-08 2004-06-05 오리엔트 캔서 세라피 컴퍼니 리미티드 Novel method of assaying immune activity
JP2006506609A (en) * 2002-11-08 2006-02-23 セレスティス リミテッド Diagnostic assays for measuring cellular immune responses
JP4359684B2 (en) * 2003-09-17 2009-11-04 独立行政法人農業・食品産業技術総合研究機構 Test method for Johne's disease
KR20110010030A (en) * 2009-07-23 2011-01-31 주식회사 해림후코이단 Immunoassay system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040047899A (en) * 2002-10-08 2004-06-05 오리엔트 캔서 세라피 컴퍼니 리미티드 Novel method of assaying immune activity
JP2006506609A (en) * 2002-11-08 2006-02-23 セレスティス リミテッド Diagnostic assays for measuring cellular immune responses
JP4359684B2 (en) * 2003-09-17 2009-11-04 独立行政法人農業・食品産業技術総合研究機構 Test method for Johne's disease
KR20110010030A (en) * 2009-07-23 2011-01-31 주식회사 해림후코이단 Immunoassay system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YUMINAMOCHI: "Interleukin-12- and interferon-gamma-mediated natural killer cell activation by Agaricus blazei Murill", IMMUNOLOGY, vol. 121, 2007, pages 197 - 206, XP055538404 *

Also Published As

Publication number Publication date
WO2017164659A2 (en) 2017-09-28
KR20170110297A (en) 2017-10-11

Similar Documents

Publication Publication Date Title
EP3747013A4 (en) Methods and systems for determining the biological age of samples
MX2017015260A (en) Anti-gitr antibodies for cancer diagnostics.
MX2021006893A (en) Cell-free nucleic acids for the analysis of the human microbiome and components thereof.
JOP20170041B1 (en) Anti-Vista (B7H5) Antibodies
EP3165556A3 (en) Protein-containing adhesives, and manufacture and use thereof
WO2017164659A3 (en) Method for examining ability of natural material to increase immunocompetence and method for providing customized diet using same
EP3904889A4 (en) Conveying device, sample analysis system comprising same, and sample preprocessing device
BR112016028838A2 (en) antibodies, nucleic acid, host cell, antibody production method, immunoconjugate, pharmaceutical formulation, methods of detecting human lgr5 in a biological sample, detecting a cancer, identifying a cancer patient, selecting a patient with cancer for treatment with an immunoconjugate and treatment of a cancer patient
EP3575779A4 (en) Method of detecting biological material, and chemiluminescent indicator used therein
HUE053453T2 (en) Immunoassay for whole blood samples
EP3869198A3 (en) Reagents and methods for breast cancer detection
EP4253960A3 (en) Materials and methods for assessing cancer risk and treating cancer
MX2019005166A (en) Antigens for detecting toxoplasma infection by monitoring cellular immunity.
WO2016168741A8 (en) Detection of human cytomegalovirus
EP3916375A4 (en) Biological sample detection device
EP3762029A4 (en) Paper-based collection and test devices for biological samples
PL401502A1 (en) Epitope and its use
EP3418728A4 (en) Sample collection device, sample collection method, and fluorescent x-ray analysis device employing same
WO2015193738A3 (en) Methods and biomarkers for analysis of colorectal cancer
EP4048153A4 (en) Biological sample collection pad
CL2018001084A1 (en) Artificial diet for the breeding of rhyzobius lophanthae, family coccinellidae, natural enemy of scales (coccoidea), method of diet preparation.
EP3996500A4 (en) Pupae singulator and sex sorter
UA104419U (en) The method of predicting fracture
WO2016112261A3 (en) Assay to detect human dpp-4
WO2019020807A1 (en) Cd9p-1-targeting antibody and uses thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17770629

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 17770629

Country of ref document: EP

Kind code of ref document: A2